Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2013 (2013), Article ID 962038, 17 pages
http://dx.doi.org/10.1155/2013/962038
Review Article

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche (IGM-CNR), Via Abbiategrasso 207, 27100 Pavia, Italy

Received 30 May 2013; Accepted 12 August 2013

Academic Editor: Claudio Sette

Copyright © 2013 Serena Bonomi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [44 citations]

The following is the list of published articles that have cited the current article.

  • Vladimir N. Uversky, “Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators,” Frontiers in Molecular Biosciences, vol. 1, 2014. View at Publisher · View at Google Scholar
  • Julia Dotterweich, Regina Ebert, Sabrina Kraus, Robert J. Tower, Franz Jakob, and Norbert Schuetze, “Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells,” Cell Communication and Signaling, vol. 12, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Biamonti, Morena Catillo, Daniela Pignataro, Alessandra Montecucco, and Claudia Ghigna, “The alternative splicing side of cancer,” Seminars in Cell & Developmental Biology, 2014. View at Publisher · View at Google Scholar
  • Anna Wojtuszkiewicz, Yehuda G Assaraf, Marielle JP Maas, Gertjan JL Kaspers, Gerrit Jansen, and Jacqueline Cloos, “Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Stefan Haug, Dominik Schnerch, Sebastian Halbach, Justin Mastroianni, Verónica I. Dumit, Marie Follo, Annette Hasenburg, Martin Köhler, Heide Dierbach, Sebastian Herzog, Amelie Proske, Martin Werner, Joern Dengjel, Tilman Brummer, Silke Laßmann, Ralph Wäsch, and Robert Zeiser, “Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Elisa Oltra, “Relevance of Splicing on Tumor-Released Exosome Landscape: Implications in Cancer Therapeutics,” Frontiers in Endocrinology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Yuchen Sun, Tomomi Furihata, Seiya Ishii, Miki Nagai, Manami Harada, Osamu Shimozato, Takehiko Kamijo, Shinichiro Motohashi, Ichiro Yoshino, Atsuko Kamiichi, Kaoru Kobayashi, and Kan Chiba, “Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers,” Clinical and Translational Medicine, vol. 3, no. 1, pp. 37, 2014. View at Publisher · View at Google Scholar
  • S Calabretta, P Bielli, I Passacantilli, E Pilozzi, V Fendrich, G Capurso, G Delle Fave, and C Sette, “Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells,” Oncogene, 2015. View at Publisher · View at Google Scholar
  • Mei-Kuang Chen, and Mien-Chie Hung, “Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases,” FEBS Journal, 2015. View at Publisher · View at Google Scholar
  • Takahiro Kishikawa, Motoyuki Otsuka, Motoko Ohno, Takeshi Yoshikawa, Akemi Takata, and Kazuhiko Koike, “Circulating RNAs as new biomarkers for detecting pancreatic cancer,” World Journal of Gastroenterology, vol. 21, no. 28, pp. 8527–8540, 2015. View at Publisher · View at Google Scholar
  • Zhaohui Li, Yu Tian, Nan Tian, Xingli Zhao, Chao Du, Liang Han, and Haishan Zhang, “Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma,” Oncology Reports, vol. 33, no. 6, pp. 2845–2852, 2015. View at Publisher · View at Google Scholar
  • M.D. Welch, M. Howlett, H.M. Halse, W.K. Greene, and U.R. Kees, “Novel CT domain-encoding splice forms of CTGF/CCN2 are expressed in B-lineage acute lymphoblastic leukemia,” Leukemia Research, 2015. View at Publisher · View at Google Scholar
  • H-C Wang, Y Yang, S-Y Xu, J Peng, J-H Jiang, and C-Y Li, “The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells,” Oral Diseases, 2015. View at Publisher · View at Google Scholar
  • D. F. Comiskey, A. G. Jacob, R. K. Singh, A. S. Tapia-Santos, and D. S. Chandler, “Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage,” Nucleic Acids Research, 2015. View at Publisher · View at Google Scholar
  • Endre Sebestyen, Michal Zawisza, and Eduardo Eyras, “Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer,” Nucleic Acids Research, vol. 43, no. 3, pp. 1345–1356, 2015. View at Publisher · View at Google Scholar
  • Biplab Dasgupta, and Rishi Raj Chhipa, “Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer,” Trends in Pharmacological Sciences, 2015. View at Publisher · View at Google Scholar
  • Cristina Panuzzo, Davide Torti, Alessandro Morotti, Maria Pilar Camacho-Leal, Paola Defilippi, Ornella Marelli, Giuseppe Saglio, Gisella Volpe, Elisa Cibrario Rocchietti, Claudia Casnici, Katia Crotta, Sabrina Crivellaro, Giovanna Carrà, Roberta Lorenzatti, and Barbara Peracino, “New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia,” Oncoscience, vol. 2, no. 10, pp. 880–891, 2015. View at Publisher · View at Google Scholar
  • Peng Guo, Dan Wang, Jun Wu, Junjun Yang, Tong Ren, Baoli Zhu, and Yang Xiang, “The landscape of alternative splicing in cervical squamous cell carcinoma,” Oncotargets And Therapy, vol. 8, pp. 73–79, 2015. View at Publisher · View at Google Scholar
  • Maria Roméria da Silva, Gabriela Alves Moreira, Ronni Anderson Gonçalves da Silva, Éverton de Almeida Alves Barbosa, Raoni Pais Siqueira, Róbson Ricardo Teixera, Márcia Rogéria Almeida, Abelardo Silva Júnior, Juliana Lopes Rangel Fietto, and Gustavo Costa Bressan, “Splicing Regulators and Their Roles in Cancer Biology and Therapy,” BioMed Research International, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Paola Frisone, Davide Pradella, Anna Di Matteo, Elisa Belloni, Claudia Ghigna, and Maria Paola Paronetto, “SAM68: Signal Transduction and RNA Metabolism in Human Cancer,” BioMed Research International, vol. 2015, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Kazushi Inoue, and Elizabeth A. Fry, “Aberrant splicing of estrogen receptor, HER2, and CD44 genes in breast cancer,” Genetics and Epigenetics, vol. 1, no. 7, pp. 19–32, 2015. View at Publisher · View at Google Scholar
  • Sara Manna, Anna Malfitano, Anna Russo, Ettore Novellino, and Daniela Marasco, “Molecular signaling involving intrinsically disordered proteins in prostate cancer,” Asian Journal of Andrology, vol. 18, no. 5, pp. 673–681, 2016. View at Publisher · View at Google Scholar
  • Stacey D. Wagner, Adam J. Struck, Riti Gupta, Dylan R. Farnsworth, Amy E. Mahady, Katy Eichinger, Charles A. Thornton, Eric T. Wang, and J. Andrew Berglund, “Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy,” PLOS Genetics, vol. 12, no. 9, pp. e1006316, 2016. View at Publisher · View at Google Scholar
  • Andrea Mathe, Michelle Wong-Brown, Warwick J. Locke, Clare Stirzaker, Stephen G. Braye, John F. Forbes, Susan J. Clark, Kelly A. Avery-Kiejda, and Rodney J. Scott, “DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients,” Scientific Reports, vol. 6, pp. 33435, 2016. View at Publisher · View at Google Scholar
  • Andrea Pellagatti, and Jacqueline Boultwood, “Splicing factor gene mutations in the myelodysplastic syndromes: Impact on disease phenotype and therapeutic applications,” Advances in Biological Regulation, 2016. View at Publisher · View at Google Scholar
  • Marie-Pier Tremblay, Victoria E. S. Armero, Andréa Allaire, Simon Boudreault, Camille Martenon-Brodeur, Mathieu Durand, Elvy Lapointe, Philippe Thibault, Maude Tremblay-Létourneau, Jean-Pierre Perreault, Michelle S. Scott, and Martin Bisaillon, “Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma,” BMC Genomics, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Muge Sarper, Ernesto Cortes, Tyler J. Lieberthal, and Armando del Río Hernández, “ATRA modulates mechanical activation of TGF-β by pancreatic stellate cells,” Scientific Reports, vol. 6, pp. 27639, 2016. View at Publisher · View at Google Scholar
  • Ying Li, and Yuan Yuan, “Alternative RNA splicing and gastric cancer,” Mutation Research/Reviews in Mutation Research, 2016. View at Publisher · View at Google Scholar
  • Lucy F. Donaldson, and Nicholas Beazley-Long, “Alternative RNA splicing: contribution to pain and potential therapeutic strategy,” Drug Discovery Today, 2016. View at Publisher · View at Google Scholar
  • Charlette Tiloke, Alisa Phulukdaree, Krishnan Anand, Robert M. Gengan, and Anil A. Chuturgoon, “ Moringa oleifera Gold Nanoparticles Modulate Oncogenes, Tumor Suppressor Genes, and Caspase-9 Splice Variants in A549 Cells ,” Journal of Cellular Biochemistry, vol. 117, no. 10, pp. 2302–2314, 2016. View at Publisher · View at Google Scholar
  • Clémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, François Aubin, Eric Toussirot, Francine Garnache-Ottou, Yann Godet, Loïc Ysebaert, Olivier Tournilhac, Dartigeas Caroline, Fabrice Larosa, Eric Deconinck, Philippe Saas, Christophe Borg, Marina Deschamps, and Christophe Ferrand, “New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies,” Experimental Hematology & Oncology, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Zhaohui Li, Qingwei Li, Liang Han, Nan Tian, Qianlei Liang, Yanzhe Li, Xingli Zhao, Chao Du, and Yu Tian, “Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines,” Oncology Reports, vol. 35, no. 2, pp. 1013–1019, 2016. View at Publisher · View at Google Scholar
  • Anastasiya Vladimirovna Snezhkina, Dmitriy Vladimitovich Kochetkov, Maria Sergeena Fedorova, Nadezhda Nikolaevna Volchenko, Nataliya Vladimirovna Melnikova, Dmitry Vladimirovich Sidorov, Anatoly Yurievich Popov, Andrey Dmitrievich Kaprin, Boris Yakovlevich Alekseev, George Sergeevich Krasnov, Anna Viktorovna Kudryavtseva, Andrew Rostislavovich Zaretsky, Alexey Alexandrovich Moskalev, Irina Yurievna Karpova, Asiya Fayazovna Sadritdinova, Dmitry Valerievich Kalinin, Alexey Alexandrovich Dmitriev, Alex Zhavoronkov, Kirill Mikhailovich Nyushko, Anastasiya Isaevna Afremova, and Anastasiya Valerievna Lipatova, “Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer,” BMC Genomics, vol. 17, 2016. View at Publisher · View at Google Scholar
  • María Laura Matos, Lara Lapyckyj, Marina Rosso, María José Besso, María Victoria Mencucci, Clara Isabel Marín Briggiler, Silvina Giustina, Laura Inés Furlong, and Mónica Hebe Vazquez-Levin, “Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events,” Journal of Cellular Physiology, 2016. View at Publisher · View at Google Scholar
  • Vladimir N. Uversky, “(Intrinsically disordered) splice variants in the proteome: implications for novel drug discovery,” Genes & Genomics, 2016. View at Publisher · View at Google Scholar
  • Nancy Martínez-Montiel, Nora Hilda Rosas-Murrieta, Mónica Martínez-Montiel, Mayra Patricia Gaspariano-Cholula, and Rebeca D. Martínez-Contreras, “Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment,” BioMed Research International, vol. 2016, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Tieju Liu, Yi Wang, Huizhi Sun, Xueyi Dong, Fang Liu, Xiaohui Liang, Baocun Sun, Dongwang Zhu, Chen Chen, Bing Shao, and Meili Wang, “TRA2A promoted paclitaxel resistance and tumor progression in triple-negative breast cancers via regulating alternative splicing,” Molecular Cancer Therapeutics, vol. 16, no. 7, pp. 1377–1388, 2017. View at Publisher · View at Google Scholar
  • Javier Gaytan-Cervantes, Carolina Gonzalez-Torres, Vilma Maldonado, Cecilia Zampedri, Gisela Ceballos-Cancino, and Jorge Melendez-Zajgla, “Protein Sam68 regulates the alternative splicing of survivin DEx3,” Journal of Biological Chemistry, vol. 292, no. 33, pp. 13745–13757, 2017. View at Publisher · View at Google Scholar
  • Victoria E.S. Armero, Maude Tremblay-Létourneau, Jean-Pierre Perreault, Michelle S. Scott, Martin Bisaillon, Marie-Pier Tremblay, Andréa Allaire, Simon Boudreault, Camille Martenon-Brodeur, Cyntia Duval, Mathieu Durand, Elvy Lapointe, and Philippe Thibault, “Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virusassociated gastric carcinomas,” PLoS ONE, vol. 12, no. 5, 2017. View at Publisher · View at Google Scholar
  • L. M. Gallego-Paez, M. C. Bordone, A. C. Leote, N. Saraiva-Agostinho, M. Ascensão-Ferreira, and N. L. Barbosa-Morais, “Alternative splicing: the pledge, the turn, and the prestige,” Human Genetics, 2017. View at Publisher · View at Google Scholar
  • Arvydas Kanopka, “Cell survival: interplay between hypoxia and pre-mRNA splicing,” Experimental Cell Research, 2017. View at Publisher · View at Google Scholar
  • Nonkululeko N. Mthembu, Zukile Mbita, Rodney Hull, and Zodwa Dlamini, “Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers,” HIV/AIDS - Research and Palliative Care, vol. 9, pp. 77–93, 2017. View at Publisher · View at Google Scholar
  • D. Flodrova, L. Toporova, M. Lastovickova, D. Macejova, L. Hunakova, J. Brtko, and J. Bobalova, “Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics,” Toxicology Letters, vol. 281, pp. 26–34, 2017. View at Publisher · View at Google Scholar
  • Davide Pradella, Chiara Naro, Claudio Sette, and Claudia Ghigna, “EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression,” Molecular Cancer, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar